HealthDay on MSN9h
Pre-Op Immunotherapy May Help Treat Aggressive Breast Cancers
Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a n ...
Science Daily14h
Trastuzumab emtansine improves long-term survival in HER2 breast cancer
In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...